Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Free Radical Biology & Medicine

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.freeradbiomed.2013.04.017PMID 23602907PMCID PMC3722255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

  2012cited by this paper
• Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice

  2012cited by this paper
• Dithiol-based Compounds Maintain Expression of Antioxidant Protein Peroxiredoxin 1 That Counteracts Toxicity of Mutant Huntingtin*

  2012cited by this paper
• Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.

  2012influential reference
• Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

  2012cited by this paper
• PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease.

  2012cited by this paper
• PGC-1α Rescues Huntington’s Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function

  2012cited by this paper
• 8OHdG as a marker for Huntington disease progression.

  2012cited by this paper
• trans-(−)-ϵ-Viniferin Increases Mitochondrial Sirtuin 3 (SIRT3), Activates AMP-activated Protein Kinase (AMPK), and Protects Cells in Models of Huntington Disease*

  2012cited by this paper
• Reagents that block neuronal death from Huntington’s disease also curb oxidative stress

  2012cited by this paper
• Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease.

  2012cited by this paper
• Molecular Characterization of Skeletal Muscle Atrophy in the R6/2 Mouse Model of Huntington's Disease

  2011cited by this paper
• In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production*

  2011cited by this paper
• Sirt1 mediates neuroprotection from mutant huntingtin by activation of TORC1 and CREB transcriptional pathway

  2011cited by this paper
• Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.

  2011cited by this paper
• Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease

  2011cited by this paper
• Neuroprotective effects of creatine

  2011cited by this paper
• Topoisomerase 1 and Single-Strand Break Repair Modulate Transcription-Induced CAG Repeat Contraction in Human Cells

  2011cited by this paper
• Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.

  2011cited by this paper
• Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models*

  2011cited by this paper
• Ku 70 Alleviates Neurodegeneration in Drosophila Models of Huntington ’ s Disease

  2011cited by this paper
• Age‐related instability in spermatogenic cell nuclear and mitochondrial DNA obtained from Apex1 heterozygous mice

  2011cited by this paper
• Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets

  2011cited by this paper
• Huntington's disease - neuropathology.

  2011cited by this paper
• Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.

  2011cited by this paper
• Expanded CAG/CTG Repeat DNA Induces a Checkpoint Response That Impacts Cell Proliferation in Saccharomyces cerevisiae

  2011cited by this paper
• MUTANT HUNTINGTIN BINDS THE MITOCHONDRIAL FISSION GTPASE DRP1 AND INCREASES ITS ENZYMATIC ACTIVTY

  2011cited by this paper
• Bioenergetic dysfunction in Huntington's disease human cybrids.

  2011cited by this paper
• Premutation huntingtin allele adopts a non-B conformation and contains a hot spot for DNA damage.

  2011cited by this paper
• Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.

  2010cited by this paper
• Impaired Brain Creatine Kinase Activity in Huntington’s Disease

  2010cited by this paper
• Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease

  2010cited by this paper
• Mechanisms of trinucleotide repeat instability during human development

  2010cited by this paper
• Huntington disease

  2010cited by this paper
• Sirtuins: common targets in aging and in neurodegeneration.

  2010cited by this paper
• Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.

  2010cited by this paper
• Huntington’s disease: pathogenesis to animal models

  2010cited by this paper
• Potassium bromate, a potent DNA oxidizing agent, exacerbates germline repeat expansion in a fragile X premutation mouse model

  2010cited by this paper
• Sirtuin 3, a New Target of PGC-1α, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis

  2010cited by this paper
• Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism.

  2010cited by this paper
• Suppression of polyglutamine‐induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis

  2010cited by this paper
• Mutant huntingtin impairs Ku70-mediated DNA repair

  2010cited by this paper
• Abnormal morphology of peripheral cell tissues from patients with Huntington disease

  2009cited by this paper
• Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons.

  2009cited by this paper
• Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

  2009cited by this paper
• Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription

  2009cited by this paper
• Impaired PGC-1alpha function in muscle in Huntington's disease.

  2009cited by this paper
• Effects of overexpression of huntingtin proteins on mitochondrial integrity.

  2009cited by this paper
• Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

  2009cited by this paper
• Stoichiometry of Base Excision Repair Proteins Correlates with Increased Somatic CAG Instability in Striatum over Cerebellum in Huntington's Disease Transgenic Mice

  2009cited by this paper
• Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.

  2009cited by this paper
• Coordination between Polymerase β and FEN1 Can Modulate CAG Repeat Expansion*

  2009cited by this paper
• DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates

  2009cited by this paper
• N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

  2008cited by this paper
• Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases.

  2008cited by this paper
• Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

  2008cited by this paper
• Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease

  2008cited by this paper
• The relationship between CAG repeat length and clinical progression in Huntington's disease

  2008cited by this paper
• A Role for Oxidized DNA Precursors in Huntington's Disease–Like Striatal Neurodegeneration

  2008cited by this paper
• Mitochondrial DNA damage and repair in neurodegenerative disorders.

  2008cited by this paper
• Spare Respiratory Capacity Rather Than Oxidative Stress Regulates Glutamate Excitotoxicity after Partial Respiratory Inhibition of Mitochondrial Complex I with Rotenone

  2007cited by this paper
• Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease

  2007cited by this paper
• Cellular and subcellular localization of Huntingtin aggregates in the brain of a rat transgenic for Huntington disease

  2007cited by this paper
• Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects

  2007cited by this paper
• Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.

  2007cited by this paper
• OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells

  2007cited by this paper
• Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.

  2007cited by this paper
• Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III.

  2006cited by this paper
• Huntingtin inclusion bodies are iron‐dependent centers of oxidative events

  2006cited by this paper
• Oxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington’s Disease

  2006cited by this paper
• Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

  2006cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells

  2006cited by this paper
• Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

  2006cited by this paper
• Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction.

  2006cited by this paper
• Transcriptional Repression of PGC-1a by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

  2006cited by this paper
• Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.

  2006cited by this paper
• Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells

  2006cited by this paper
• Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects

  2006cited by this paper
• Faculty Opinions recommendation of Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.

  2006cited by this paper
• Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation.

  2006cited by this paper
• Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant

  2006cited by this paper
• Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP

  2005cited by this paper
• Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

  2005cited by this paper
• The Intracellular Localization of APE1/Ref-1: More than a Passive Phenomenon?

  2005cited by this paper
• The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress.

  2005cited by this paper
• Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice

  2005cited by this paper
• 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

  2005cited by this paper
• Cognitive changes in Huntington's disease.

  2005cited by this paper
• Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin*

  2005cited by this paper
• Acute Glutathione Depletion Restricts Mitochondrial ATP Export in Cerebellar Granule Neurons*

  2005cited by this paper
• HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.

  2005cited by this paper
• Spontaneous Mutagenesis Is Enhanced in Apex Heterozygous Mice

  2004cited by this paper
• Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.

  2004cited by this paper
• Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro

  2004cited by this paper
• Increased Formation of Reactive Oxygen Species, but No Changes in Glutathione Peroxidase Activity, in Striata of Mice Transgenic for the Huntington's Disease Mutation

  2004cited by this paper
• Analysis of Human Flap Endonuclease 1 Mutants Reveals a Mechanism to Prevent Triplet Repeat Expansion*

  2003cited by this paper
• DNA damage induced by polyglutamine-expanded proteins.

  2003cited by this paper
• Oxidative α-Ketoglutarate Dehydrogenase Inhibition via Subtle Elevations in Monoamine Oxidase B Levels Results in Loss of Spare Respiratory Capacity

  2003cited by this paper
• Nuclease-Deficient FEN-1 Blocks Rad51/BRCA1-Mediated Repair and Causes Trinucleotide Repeat Instability

  2003cited by this paper

• F2,6BP restores mitochondrial genome integrity in Huntington's Disease.

  2026cites this paper
• Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases

  2026cites this paper
• Mitochondria and oxidative stress in epilepsy: advances in antioxidant therapy

  2025cites this paper
• Iron metabolism and ferroptosis in health and diseases: the crucial role of mitochondria in meta-bolically active tissues.

  2025cites this paper
• Baicalein-mediated regulation of Nrf2/ARE, NFĸB, and MAPK signaling in Huntington’s disease: a promising strategy against neuroinflammation and neurodegeneration

  2025cites this paper
• Stress and neurodegeneration: mechanistic insights and therapeutic opportunities for preserving brain resilience.

  2025cites this paper
• Detecting mtDNA Effects with an Extended Pedigree Model: An Analysis of Statistical Power and Estimation Bias

  2025cites this paper
• Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington’s disease

  2025cites this paper
• Ferulic acid mitigates 3-Nitropropionic acid-induced Huntington’s disease via modulation of Nrf2/HO-1, TLR4/NF-κB, and SIRT1/p53 signaling pathways

  2025cites this paper
• Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease

  2025cites this paper
• Oxidative Stress and Mitochondrial Impairment: Key Drivers in Neurodegenerative Disorders.

  2025cites this paper
• DNA/RNA hybrid profiling in autistic patients: A focus on mRNA and non-coding RNA variations

  2025cites this paper
• DNA damage response regulator ATR licenses PINK1-mediated mitophagy

  2025cites this paper
• Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification

  2024cites this paper
• F2,6BP restores mitochondrial genome integrity in Huntington’s Disease

  2024cites this paper
• m6A modification of mutant huntingtin RNA promotes the biogenesis of pathogenic huntingtin transcripts

  2024influential citation
• The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks

  2024cites this paper
• E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.

  2024cites this paper
• Bu zhong Yiqi Decoction ameliorates mild cognitive impairment by improving mitochondrial oxidative stress damage via the SIRT3/MnSOD/OGG1 pathway.

  2024cites this paper
• Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

  2024cites this paper
• Polymerase and Proofreading Exonuclease Domains in the DNA Polymerase γ and Nuclear-encoded RNA Polymerase of the Human Mitochondria and Identification of Mitochondrial Disease Mutations in the Polymerase Active Site Region of DNA Polymerase γ

  2024cites this paper
• Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

  2024cites this paper
• Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds

  2023cites this paper
• Molecular mechanisms of ferroptosis and their involvement in brain diseases.

  2023cites this paper
• Oxidative stress and neurodegenerative diseases: Exploring natural antioxidants for therapeutic potential

  2023cites this paper
• Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases

  2023cites this paper
• Recombinant human erythropoietin and interferon-β-1b protect against 3-nitropropionic acid-induced neurotoxicity in rats: possible role of JAK/STAT signaling pathway

  2022cites this paper
• Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1/TLR4/NF-κB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats.

  2022cites this paper
• New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis

  2022cites this paper
• Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington’s Disease

  2022cites this paper
• Role and mechanism of ferroptosis in neurological diseases

  2022cites this paper
• Mitochondrial DNA-dependent inflammation in kidney diseases.

  2022cites this paper
• Exercise sustains the hallmarks of health

  2022cites this paper
• Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer's Disease and Huntington's Disease

  2022cites this paper
• Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway.

  2022cites this paper
• Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease

  2022cites this paper
• Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases

  2022cites this paper
• Protective Effects of Polysaccharides in Neurodegenerative Diseases

  2022cites this paper
• Basic Leucine Zipper Protein Nuclear factor erythroid 2-related factor 2 as a Potential Therapeutic Target in Brain Related Disorders.

  2022cites this paper
• Mitochondrial Function and Dynamics in Neural Stem Cells and Neurogenesis: Implications for Neurodegenerative Diseases.

  2022cites this paper
• Aptamers Targeting Hallmark Proteins of Neurodegeneration

  2022cites this paper
• Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration

  2021cites this paper
• Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions

  2021cites this paper
• A pioneer study on human 3‐nitropropionic acid intoxication: Contributions from metabolomics

  2021cites this paper
• Alleviation of Cadmium Chloride–Induced Acute Genotoxicity, Mitochondrial DNA Disruption, and ROS Generation by Chocolate Coadministration in Mice Liver and Kidney Tissues

  2021cites this paper
• Huntingtin Maintains Mitochondrial Genome Integrity and Function

  2021cites this paper
• Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics

  2021cites this paper
• Pathogenesis of Neurodegeneration and Associated Neurological Disorders

  2021cites this paper
• Lost in the Crowd: How Does Human 8-Oxoguanine DNA Glycosylase 1 (OGG1) Find 8-Oxoguanine in the Genome?

  2020cites this paper
• Oxytocin Prevents the Development of 3-NP-Induced Anxiety and Depression in Male and Female Rats: Possible Interaction of OXTR and mGluR2

  2020cites this paper
• Cell and Tissue Destruction in Selected Disorders

  2020cites this paper
• MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model

  2020cites this paper
• Nucleic acid therapeutics: a focus on the development of aptamers

  2020cites this paper
• Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study

  2020influential citation
• Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

  2020cites this paper
• Cockayne Syndrome: The many challenges and approaches to understand a multifaceted disease

  2020cites this paper
• Harmine Acts as an Indirect Inhibitor of Intracellular Protein Aggregation

  2020cites this paper
• AluYb8 insertion polymorphism in the MUTYH gene impairs mitochondrial DNA maintenance and affects the age of onset of IPF

  2019cites this paper
• Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington's disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors.

  2019cites this paper
• Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems

  2019cites this paper
• El papel de las especies reactivas de oxígeno y nitrógeno en algunas enfermedades neurodegenerativas

  2019cites this paper
• Reactive oxygen species in status epilepticus.

  2019cites this paper
• MECHANISMS OF TRINUCLEOTIDE REPEAT INSTABILITY DURING DNA SYNTHESIS

  2019cites this paper
• Telomere length analysis on leukocytes derived from patients with Huntington Disease.

  2019cites this paper
• Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signalled to DNA damage by Ataxia Telangiectasia Mutated kinase

  2019cites this paper
• PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

  2019cites this paper
• The Emerging Roles of Ferroptosis in Huntington’s Disease

  2019influential citation
• Estimation of genomic instability and mitochondrial DNA damage induction by acute oral administration of calcium hydroxide normal- and nano- particles in mice.

  2019cites this paper
• Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells

  2018cites this paper
• Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones

  2018cites this paper
• Melatonin: A Versatile Protector against Oxidative DNA Damage

  2018cites this paper
• Investigating structure–property relationships of biomineralized calcium phosphate compounds as fluorescent quenching–recovery platform

  2018cites this paper
• Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington’s disease

  2018cites this paper
• GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons

  2018cites this paper
• Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease.

  2018cites this paper
• Novel DNA Aptamers that Bind to Mutant Huntingtin and Modify Its Activity

  2018cites this paper
• Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.

  2018cites this paper
• RNA Aptamers Rescue Mitochondrial Dysfunction in a Yeast Model of Huntington’s Disease

  2018cites this paper
• Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis

  2018cites this paper
• Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

  2018cites this paper
• Melatonin and its metabolites as chemical agents capable of directly repairing oxidized DNA

  2018cites this paper
• Manifestations of Drug Toxicity on Mitochondria in the Nervous System

  2018cites this paper
• Analysis of Huntingtin Protein Aggregation Mechanisms and the Development of a Clinically-Derived Human Cell Model of Huntington's Disease

  2018cites this paper
• Oxidative stress, cell cycle arrest, DNA damage and apoptosis in adult zebrafish (Danio rerio) induced by tris(1,3-dichloro-2-propyl) phosphate.

  2018cites this paper
• Not breathing is not an option: How to deal with oxidative DNA damage.

  2017cites this paper
• The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

  2017cites this paper
• Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model

  2017cites this paper
• Repair of 8‐oxo‐7,8‐dihydroguanine in prokaryotic and eukaryotic cells: Properties and biological roles of the Fpg and OGG1 DNA N‐glycosylases☆

  2017cites this paper
• Risky repair: DNA-protein crosslinks formed by mitochondrial base excision DNA repair enzymes acting on free radical lesions.

  2017cites this paper
• Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders

  2017cites this paper
• Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington's disease-like symptoms in mice.

  2017cites this paper
• Neurodegeneration caused by accumulation of an oxidized base lesion, 8-oxoguanine, in nuclear and mitochondrial DNA: from animal models to human diseases.

  2017cites this paper
• Transcriptional control of amino acid homeostasis is disrupted in Huntington’s disease

  2016cites this paper
• Ethanol extract of Prunus mume fruit attenuates hydrogen peroxide-induced oxidative stress and apoptosis involving Nrf2/HO-l activation in C2C12 myoblasts

  2016cites this paper
• Biochemical and behavioral evidences for neuromodulatory properties of Selaginella delicatula against 3-nitropropionic acid model in mice

  2016cites this paper
• Exercise-induced oxidatively damaged DNA in humans: evaluation in plasma or urine?

  2016cites this paper
• Etude des mécanismes d'action du Strontium 90 sur le système immunitaire à la suite d'une contamination chronique

  2016influential citation
• HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases

  2016cites this paper
• Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons

  2016cites this paper
• Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex

  2016cites this paper